DK148989A - Alkanophenorer - Google Patents

Alkanophenorer

Info

Publication number
DK148989A
DK148989A DK148989A DK148989A DK148989A DK 148989 A DK148989 A DK 148989A DK 148989 A DK148989 A DK 148989A DK 148989 A DK148989 A DK 148989A DK 148989 A DK148989 A DK 148989A
Authority
DK
Denmark
Prior art keywords
optionally
lower alkyl
salt
denotes
obtainable according
Prior art date
Application number
DK148989A
Other languages
Danish (da)
English (en)
Other versions
DK148989D0 (da
Inventor
Andreas Von Sprecher
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK148989D0 publication Critical patent/DK148989D0/da
Publication of DK148989A publication Critical patent/DK148989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
DK148989A 1988-03-29 1989-03-28 Alkanophenorer DK148989A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH118688 1988-03-29
CH385788 1988-10-14

Publications (2)

Publication Number Publication Date
DK148989D0 DK148989D0 (da) 1989-03-28
DK148989A true DK148989A (da) 1989-09-30

Family

ID=25686932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK148989A DK148989A (da) 1988-03-29 1989-03-28 Alkanophenorer

Country Status (19)

Country Link
EP (1) EP0335315B1 (ja)
JP (1) JP2777183B2 (ja)
KR (1) KR0125933B1 (ja)
AT (1) ATE107639T1 (ja)
AU (1) AU623383B2 (ja)
CA (1) CA1340463C (ja)
CY (1) CY1967A (ja)
DE (1) DE58907920D1 (ja)
DK (1) DK148989A (ja)
ES (1) ES2056137T3 (ja)
FI (1) FI94342C (ja)
HK (1) HK192696A (ja)
HU (2) HU202852B (ja)
IE (1) IE66248B1 (ja)
IL (1) IL89713A0 (ja)
NO (1) NO171555C (ja)
NZ (1) NZ228477A (ja)
PT (1) PT90125B (ja)
YU (1) YU63089A (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
ES2214536T3 (es) 1995-04-14 2004-09-16 Smithkline Beecham Corporation Inhalador dosificador de dipropionato de beclometasona.
AP960A (en) 1995-04-14 2001-04-20 Glaxo Wellcome Inc Metered dose inhaler for fluticasone propionate.
CN1142798C (zh) 1995-04-14 2004-03-24 葛兰素惠尔康公司 沙美特罗的计定剂量吸入器
ES2292526T3 (es) 1995-04-14 2008-03-16 Smithkline Beecham Corporation Procedimiento para la preparacion de un inhalador dosificador.
IT1320162B1 (it) 2000-02-09 2003-11-18 Rotta Research Lab Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
EP1332139B1 (en) 2000-10-23 2007-04-04 Arizona Biomedical Research Commission Anticancer agents based on regulation of protein prenylation
TW200408393A (en) 2002-10-03 2004-06-01 Ono Pharmaceutical Co Antagonist of lysophosphatidine acid receptor
EP1695955B1 (en) * 2003-12-19 2011-10-12 Ono Pharmaceutical Co., Ltd. Compounds having lysophosphatidic acid receptor antagonism and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14579T1 (de) * 1979-03-20 1985-08-15 Fisons Plc Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
EP0079637B1 (en) * 1981-11-12 1987-01-28 FISONS plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones

Also Published As

Publication number Publication date
HK192696A (en) 1996-10-25
FI891362A0 (fi) 1989-03-22
EP0335315B1 (de) 1994-06-22
FI94342B (fi) 1995-05-15
NZ228477A (en) 1990-11-27
YU63089A (en) 1990-12-31
FI94342C (fi) 1995-08-25
EP0335315A1 (de) 1989-10-04
KR0125933B1 (ko) 1997-12-26
CY1967A (en) 1997-07-04
DK148989D0 (da) 1989-03-28
HUT49599A (en) 1989-10-30
NO171555C (no) 1993-03-31
CA1340463C (en) 1999-03-23
PT90125B (pt) 1994-10-31
ATE107639T1 (de) 1994-07-15
AU623383B2 (en) 1992-05-14
HU202852B (en) 1991-04-29
IL89713A0 (en) 1989-09-28
JP2777183B2 (ja) 1998-07-16
NO171555B (no) 1992-12-21
FI891362A (fi) 1989-09-30
DE58907920D1 (de) 1994-07-28
IE890935L (en) 1989-09-29
HU210531A9 (en) 1995-04-28
JPH01299283A (ja) 1989-12-04
NO891286L (no) 1989-10-02
NO891286D0 (no) 1989-03-28
ES2056137T3 (es) 1994-10-01
PT90125A (pt) 1989-11-10
AU3225289A (en) 1989-10-12
IE66248B1 (en) 1995-12-27
KR890014511A (ko) 1989-10-24

Similar Documents

Publication Publication Date Title
KR900006318A (ko) 피페리디닐 벤즈이미다졸
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
KR870001142A (ko) 페닐 에테르의 제법
AU515774B2 (en) Benzopyran derivatives
DK148989A (da) Alkanophenorer
KR910020006A (ko) 옥사졸리디논
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
KR890001965A (ko) 스퍼구알린 관련 유도체
KR890001969A (ko) 황화합물, 이들의 제법 및 이들을 함유하는 제약학적 조성물
SE8100846L (sv) Antirinovirusmedel
FI832582A (fi) Foerfarande foer framstaellning av nya tieno-tiazol-derivat och dessa foereningar innehaollande laekemedel
KR870010034A (ko) 3-카바모일-4-하이드록시-쿠마린 및 이의 제조방법
ES2053868T3 (es) 3-aminosidnoniminas substituidas, procedimientos para su obtencion y su empleo.
IL87796A0 (en) Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them
KR930005953A (ko) 리그난, 이의 중간체 및 이러한 중간체의 제조방법
KR890009903A (ko) 뇌부전증 개선제로서 유효한 신규 화합물
NO874627D0 (no) Fremgangsmaate for fremstilling av 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer.
YU176790A (sh) Nadaljnji novi alkanofenoni
KR830002745A (ko) 피페라진 유도체의 제법

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment